Recent news on Pediarix

GSK hit by strong sterling but underlying growth is good  -  Apr 26, 2007
Pharma Times (subscription),..."with an exceptionally high first quarter last year," but Infanrix/Pediarix combination vaccines for children did manage a 15% rise to £134 million.

GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II ...  -  May 14, 2007
PharmaLive.com (press release),4, and 6 months concomitantly with DTaP-Hep B-IPV (Pediarix ® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant)

GSK hit by strong sterling but underlying growth is good  -  26 Apr 2007
Pharma Times (subscription),..."with an exceptionally high first quarter last year," but Infanrix/Pediarix combination vaccines for children did manage a 15% rise to £134 million.

GlaxoSmithKline: Results Announcement for the First Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),Sales growth was largely driven by continued good performance of Infanrix/Pediarix, GSK’s combination vaccines for children, with sales up 15% to over £130

2007 Changes to the Immunization Schedule  -  Apr 20, 2007
Cedar City Review,Pediarix (a five vaccine combination) contains vaccines for diphtheria, tetanus, pertussis (whooping cough), polio and hepatitis B, all in one syringe and

Single dose vaccine on its way to EL  -  Feb 21, 2007
Dispatch Online,The drug, Pediarix, was recently launched in the country by Belgian pharmaceutical company GlaxoSmithKline (GSK) and, although the roll-out of the drug to

Glaxo Changes Vaccine to Take Out a Controversial Preservative  -  Jan 31, 2007
Bloomberg31 (Bloomberg) -- GlaxoSmithKline Plc, Europe's largest drugmaker, plans to begin selling a new formula of its Pediarix vaccine for children that doesn't

Sales in United States keep Glaxo figures looking healthy  -  Feb 9, 2007
Yorkshire Post Today,Overall vaccine sales rose 23 per cent to £1.7bn driven by its combination vaccines for children, Infanrix and Pediarix, and its hepatitis vaccines.

Pipeline paying dividends as GSK posts strong earnings rise  -  Feb 9, 2007
Pharma Times (subscription),GSK's vaccine sales also performed strongly, rising 31% to £527 million, driven by Infanrix/Pediarix for children, up 29% to £136 million,

Pharmaceutical giant sees five major product launches in 2007  -  Feb 8, 2007
MarketWatchInfanrix/Pediarix, a combination vaccine for children, posted a 29% rise in sales to 511 million pounds, while new sales of new vaccines -- Rotarix,

Immunization clinics set  -  Feb 8, 2007
Pontiac Daily Leader,Vaccines provided include: Pediarix (DTap, Hepatitis B, IPV); HIB (Haemophilus Influenza B - a type of flu which often results in meningitis in children

Health Highlights: Jan. 27, 2007  -  Jan 27, 2007
Forbes,Currently, the only five-component childhood vaccine available in the US is Pediarix, made by GlaxoSmithKline. It's similar to Pentacel, but protects

Research & Markets: GlaxoSmithKline - Have an Estimated Seven Per ...  -  Dec 18, 2006
PharmaLive.com (press release),Vaccines also performed well in 2005, growing by 26 per cent, reflecting a strong performance of Pediarix and Fluarix.

Don't let vaccines become a drain on your practice  -  Dec 1, 2006
AAP News (subscription)The list price for the 25 vaccines (utilizing Pediarix and ProQuad) recommended for a female patient comes to $1543, based on the current immunization

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional